Kidney Transplantation
Babak Orandi spoke with us about a study showing that GLP-1 drugs have benefits for kidney transplant recipients with T2D.
The American Kidney Fund's Living Donor Report Card found that many US states lack protections for living kidney donors.
Eledon Pharmaceuticals CEO David-Alexandre Gros, MD, spoke about the role of CD40L blocker tegoprubart in transplantation.
The KidneyVault Portable Renal Perfusion System has been used in human kidney transplants for the first time.
The NKF will invest in the NoMo Kidney Pump, a continuous perfusion system to modernize kidney preservation and storage.
Current eligibility criteria for simultaneous heart and kidney transplantation may be subject to eGFRcr errors.
An analysis sought to determine the economic costs of treating SARS-CoV-2 infection among kidney transplant recipients.
The FDA has granted United Therapeutics approval to begin a first-in-human clinical study of a gene-edited pig kidney.
A study examined the safety and noninferiority of kidney transplantation from donors with HIV to recipients with HIV.
A systematic review and meta-analysis evaluated the safety of statin use among kidney allograft recipients.
Is time to death from withdrawal of life-sustaining treatment is associated with kidney transplant outcomes?
The TRANSNEMIA study addressed the need for guidelines specific to anemia in kidney transplant recipients.
Advertisement
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.